William D. Schwieterman, Chief Medical Officer at Chelsea Therapeutics International, Ltd. (CHTP), bought 40,000 shares at $3.96 ($158K) on 2011-03-07, disclosed to the SEC on 2011-03-09.
Open-market purchase of $158k CHTP by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |